List of top 200 securities held by Aisling Capital Management LP:
- Institutional investors with $100 million or more in holdings are required to report their portfolio holdings on a quarterly basis within 45 days of the end of a calendar quarter.
- The table below lists top 200 holdings for the reported quarter.
- Portfolio values with missing quarterly reports are assigned zero.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Quarter: 2024Q4
Report Date Time: 2025-02-12 16:49:41
Total Holdings: 15
Assets Under Management (AUM) :
$281,842,244 ($281.842M)
Reporting Manager: ROBERT J. WENZEL
Address:
489 5TH AVE, 10TH FLOOR
NEW YORK, NY 10017
Since 2018-12-31: total money flow = $271.689M, gains and losses = -$84.523M
| 1 | BRIDGEBIO PHARMA INC BBIO | 2024Q4 | 6,068,125 | $166.509M ($27.44) | 59.08% |  | | History |
| 2 | VERONA PHARMA PLC SPONSORED AD VRNA | 2024Q4 | 1,115,352 | $51.797M ($46.44) | 18.38% | | | History |
| 3 | SYNDAX PHARMACEUTICALS INC SNDX | 2024Q4 | 1,025,000 | $13.551M ($13.22) | 4.81% | | | History |
| 4 | MONTE ROSA THERAPEUTICS INC CO GLUE | 2024Q4 | 1,472,331 | $10.218M ($6.94) | 3.63% | | | History |
| 5 | POSEIDA THERAPEUTICS INC PSTX | 2024Q4 | 1,043,267 | $10.015M ($9.60) | 3.55% | | | History |
| 6 | BICARA THERAPEUTICS INC BCAX | 2024Q4 | 568,919 | $9.911M ($17.42) | 3.52% | | | History |
| 7 | NUVATION BIO INC NUVB | 2024Q4 | 2,541,009 | $6.759M ($2.66) | 2.40% | | | History |
| 8 | COMPASS PATHWAYS PLC SPONSORED CMPS | 2024Q4 | 964,500 | $3.646M ($3.78) | 1.29% | | | History |
| 9 | BIOMEA FUSION INC BMEA | 2024Q4 | 798,757 | $3.099M ($3.88) | 1.10% | | | History |
| 10 | CALCIMEDICA INC CALC | 2024Q4 | 521,114 | $1.845M ($3.54) | 0.6545% | | | History |
Showing 1 to 10 of 15 entries
×